Additionally, present studies demonstrate marked dependency of CLR, RT-DLBCL cells on BRD4-regulated enhancers of oncogenes, including TCF4, IRF4, and MYC. The gene discussed is TCF4; the disease is diffuse large B-cell lymphoma.